NGM Biopharmaceuticals SG&A Expense (Quarterly) Trends

NGM Biopharmaceuticals Inc (DELISTED) (NGM:DL)

1.54 0.00 (0.00%) USD | NASDAQ | Apr 05, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	7.938M
September 30, 2023	8.671M
June 30, 2023	9.647M
March 31, 2023	11.58M
December 31, 2022	9.756M
September 30, 2022	10.11M
June 30, 2022	9.927M
March 31, 2022	10.72M
December 31, 2021	9.454M
September 30, 2021	8.867M
June 30, 2021	9.823M
March 31, 2021	8.721M

Date	Value
December 31, 2020	7.38M
September 30, 2020	6.46M
June 30, 2020	6.794M
March 31, 2020	6.595M
December 31, 2019	6.423M
September 30, 2019	5.612M
June 30, 2019	6.229M
March 31, 2019	5.367M
December 31, 2018	5.122M
September 30, 2018	4.811M
June 30, 2018	3.458M
March 31, 2018	3.874M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

5.612M

Minimum

Sep 2019

11.58M

Maximum

Mar 2023

8.459M

Average

8.721M

Median

Mar 2021

SG&A Expense (Quarterly) Benchmarks